This International Symposium provides a timely opportunity for practitioners and stakeholders across Europe to discuss the latest challenges and consider the next steps needed to win the fight against illicit drug trafficking and substance misuse through holistic, multi-level and cross-border approaches. Public Policy Exchange welcomes the participation of all key partners, responsible authorities and stakeholders. The Symposium will support the exchange of ideas and encourage delegates to engage in thought-provoking topical debate.
Preparations are gathering pace for the United Nations General Assembly Special Session (UNGASS) on drugs, to be held on the 19th to 21st April 2016 in New York. Following several months of discussion on procedural elements, attention is now focused on negotiating the content of the "short, substantive, concise and action-orientated outcome document comprising a set of operational recommendations" to be approved by the General Assembly next April. At the CND intersessional meeting on 12th June, countries and regional groups were invited to submit their first ideas for what could be included in this Outcome Document, by a deadline of 11th September.
Global disagreement over drug policies provides an important opportunity to reconsider the effectiveness of existing counternarcotics policies, address their problematic side effects, and propose evidence-based alternative strategies. Because of the differences in attitudes on drug policy around the world, a substantial revision of existing counternarcotics treaties is unlikely at UNGASS 2016. (See also: Improving global drug policy: Comparative perspectives and UNGASS 2016)
On 19th to 21st April 2016, there will be a United Nations General Assembly Special Session (UNGASS) held in New York, dedicated to the issue of drug policy. The General Assembly is the highest policy making and representative organ of the United Nations (UN), and its infrequent Special Sessions focus on pertinent topics at the request of member states. The UNGASS on drugs has the potential to be a ground-breaking, open debate about the international drug control system – but there is much work to be done to ensure that it fulfils that potential.
O quadro de referência essencialmente químico adotado pela Convenção Única das Nações Unidas é equivocado na forma culturalmente enviesada e falsamente "científica" em que foi aplicado a diferentes plantas.
The upcoming United Nations General Assembly Special Session on Drugs (UNGASS) in 2016 is an unprecedented opportunity to review and re-direct national drug control policies and the future of the global drug control regime. As diplomats sit down to rethink international and domestic drug policy, they would do well to recall the mandate of the United Nations, not least to ensure security, human rights and development.
TNI has been closely involved with the Global Commission on Drug Policy which presented its report in New York on June 2. Some years ago we published a report, entitled Cracks in the Vienna Consensus in which we argued that cracks were appearing in the supposedly universal model under the UN treaty system. In reality, the global system is based on a highly fragile consensus of Vienna, where the UN drug control system is headquartered, and the painstaking negotiations every year to keep up the appearance of unity have become the symbol of paralysis and frustration.
The global war on drugs has failed, with devastating consequences for individuals and societies around the world. Fifty years after the initiation of the UN Single Convention on Narcotic Drugs, and 40 years after President Nixon launched the US government’s war on drugs, fundamental reforms in national and global drug control policies are urgently needed.
Today the International Narcotics Control Board (INCB) released its annual report. I’ve been following the Board for many, many years now, have often criticized its narrow interpretation of the treaties, have questioned the validity of its usually negative comments about any policy changes in the direction of harm reduction or decriminalization, and have warned repeatedly about its tendency to overstep its clearly defined mandate.
At a press conference in New York on Tuesday 26 October, 2010, at the 65th session of the United Nations General Assembly, one of the UN’s key human rights experts will call for a fundamental rethink of international drug policy. Anand Grover, from India, is the UN Special Rapporteur on the Right of Everyone to the Highest Attainable Standard of Physical and Mental Health, whose mandate is derived from the UN Human Rights Council.
Anand Grover, UN Special Rapporteur for the occupied Palestinian territories
06 Agosto 2010
The current international system of drug control has focused on creating a drug-free world, almost exclusively through use of law enforcement policies and criminal sanctions. Mounting evidence, however, suggests this approach has failed, primarily because it does not acknowledge the realities of drug use and dependence. While drugs may have a pernicious effect on individual lives and society, this excessively punitive regime has not achieved its stated public health goals, and has resulted in countless human rights violations.
The Vienna Declaration is a statement seeking to improve community health and safety by calling for the incorporation of scientific evidence into illicit drug policies. We are inviting scientists, health practitioners and the public to endorse this document in order to bring these issues to the attention of governments and international agencies, and to illustrate that drug policy reform is a matter of urgent international significance. We also welcome organizational endorsements.
Recently, the UNODC has begun to take notice of the impact of its counternarcotics work on human rights. Antonio Maria Costa, the current executive director, has set out a series of recommendations for internal reform intended to improve the agency's human rights performance. This leadership on human rights is very welcome, and much needed, but it may already be under threat. Costa leaves his post at the end of July. Unfortunately, the current frontrunner for the role of UN drug tsar is the candidate being pushed by the Russian government.
TNI’s Drugs & Democracy programme analyses drug policies and trends in the illicit drugs market. TNI examines the underlying causes of drug production and consumption and the impacts of current drug policies on conflict, development,and democracy. The programme facilitates dialogue and advocates evidence-based policies, guided by principles of harm reduction and human rights for users and producers.
The academic journal Nueva Sociedad recently released an issue to promote the debate in Latin America on drug policy reform. TNI contributed with the paper "Drug policy reform in practice: Experiences with alternatives in Europe and the US".